Results 11 to 20 of about 4,105,290 (355)
Acknowledgment to Reviewers of Antibodies in 2020 [PDF]
Antibodies, 2021 Peer review is the driving force of journal development, and reviewers are gatekeepers who ensure that Antibodies maintains its standards for the high quality of its published papers [...]
Antibodies Editorial Office
doaj +2 more sources
Acknowledgement to Reviewers of Antibodies in 2014 [PDF]
Antibodies, 2015 The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2014:[...]
Antibodies Editorial Office
doaj +2 more sources
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Nature, 2021 Here we report on the antibody and memory B cell responses of a cohort of 20 volunteers who received the Moderna (mRNA-1273) or Pfizer–BioNTech (BNT162b2) vaccine against SARS-CoV-21–4. Eight weeks after the second injection of vaccine, volunteers showed
Christian Gaebler +2 more
exaly +2 more sources
Acknowledgement to Reviewers of Antibodies in 2016 [PDF]
Antibodies, 2017 The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2016.[...]
Antibodies Editorial Office
doaj +2 more sources
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies
Cell, 2021 The global spread of SARS-CoV-2/COVID-19 is devastating health systems and economies worldwide. Recombinant or vaccine-induced neutralizing antibodies are used to combat the COVID-19 pandemic. However, the recently emerged SARS-CoV-2 variants B.1.1.7 (UK)
Stefan Pohlmann +2 more
exaly +2 more sources
Acknowledgement to Reviewers of Antibodies in 2013 [PDF]
Antibodies, 2014 The editors of Antibodies would like to express their sincere gratitude to the following reviewers for assessing manuscripts in 2013.
Antibodies Editorial Office
doaj +2 more sources
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Nature, 2021 An ideal therapeutic anti-SARS-CoV-2 antibody would resist viral escape1–3, have activity against diverse sarbecoviruses4–7, and be highly protective through viral neutralization8–11 and effector functions12,13.
Martina Beltramello +2 more
exaly +2 more sources
Acknowledgment to Reviewers of Antibodies in 2021 [PDF]
Antibodies, 2022 Rigorous peer-reviews are the basis of high-quality academic publishing [...]
Antibodies Editorial Office
doaj +2 more sources
BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
Nature, 2022 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron sublineages BA.2.12.1, BA.4 and BA.5 exhibit higher transmissibility than the BA.2 lineage1.
Yunlong Cao +44 more
semanticscholar +1 more source
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
Nature, 2021 The SARS-CoV-2 B.1.1.529 (Omicron) variant contains 15 mutations of the receptor-binding domain (RBD). How Omicron evades RBD-targeted neutralizing antibodies requires immediate investigation.
Yunlong Cao +29 more
semanticscholar +1 more source